Terms: = Liver cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Diagnosis
98 results:
1. SUMOylation of annexin A6 retards cell migration and tumor growth by suppressing RHOU/AKT1-involved emt in hepatocellular carcinoma.
Yang Y; Huang L; Zhang N; Deng YN; Cao X; Liang Y; Hou H; Luo Y; Yang Y; Li Q; Liang S
Cell Commun Signal; 2024 Apr; 22(1):206. PubMed ID: 38566133
[TBL] [Abstract] [Full Text] [Related]
2. USP14 exhibits high expression levels in hepatocellular carcinoma and plays a crucial role in promoting the growth of liver cancer cells through the HK2/AKT/P62 axis.
Zhang N; Zhang H; Yang X; Xue Q; Wang Q; Chang R; Zhu L; Chen Z; Liu X
BMC Cancer; 2024 Feb; 24(1):237. PubMed ID: 38383348
[TBL] [Abstract] [Full Text] [Related]
3. Midkine (MDK) in Hepatocellular Carcinoma: More than a Biomarker.
Christou C; Stylianou A; Gkretsi V
Cells; 2024 Jan; 13(2):. PubMed ID: 38247828
[TBL] [Abstract] [Full Text] [Related]
4. N-cadherin: A diagnostic marker to help discriminate primary liver carcinomas from extrahepatic carcinomas.
Gerber TS; Ridder DA; Goeppert B; Brobeil A; Stenzel P; Zimmer S; Jäkel J; Metzig MO; Schwab R; Martin SZ; Kiss A; Bergmann F; Schirmacher P; Galle PR; Lang H; Roth W; Straub BK
Int J Cancer; 2024 May; 154(10):1857-1868. PubMed ID: 38212892
[TBL] [Abstract] [Full Text] [Related]
5. Small extracellular vesicles: Non-negligible vesicles in tumor progression, diagnosis, and therapy.
Zhou X; Jia Y; Mao C; Liu S
Cancer Lett; 2024 Jan; 580():216481. PubMed ID: 37972701
[TBL] [Abstract] [Full Text] [Related]
6. MicroRNAs and their vital role in apoptosis in hepatocellular carcinoma: miRNA-based diagnostic and treatment methods.
Hajizadeh M; Hajizadeh F; Ghaffarei S; Amin Doustvandi M; Hajizadeh K; Yaghoubi SM; Mohammadnejad F; Khiabani NA; Mousavi P; Baradaran B
Gene; 2023 Dec; 888():147803. PubMed ID: 37716587
[TBL] [Abstract] [Full Text] [Related]
7. SSNA1 Promotes Hepatocellular Carcinoma Metastasis
Wu LW; Hu X
Anticancer Res; 2023 Aug; 43(8):3479-3486. PubMed ID: 37500134
[TBL] [Abstract] [Full Text] [Related]
8. Regulation of Hepatocellular Carcinoma Epithelial-Mesenchymal Transition Mechanism and Targeted Therapeutic Approaches.
Yüregir Y; Kaçaroğlu D; Yaylacı S
Adv Exp Med Biol; 2024; 1450():93-102. PubMed ID: 37452258
[TBL] [Abstract] [Full Text] [Related]
9. AFP deletion leads to anti-tumorigenic but pro-metastatic roles in liver cancers with concomitant CTNNB1 mutations.
Xu Y; Zhang X; Zhang R; Sun Y; Liu J; Luo C; Yang J; Fang W; Guo Q; Wei L
Cancer Lett; 2023 Jul; 566():216240. PubMed ID: 37217071
[TBL] [Abstract] [Full Text] [Related]
10. RNF8 depletion attenuates hepatocellular carcinoma progression by inhibiting epithelial-mesenchymal transition and enhancing drug sensitivity.
Kuang J; Duan T; Gao C; Liu C; Chen S; Zhu LY; Min L; Lu C; Wang W; Zhu L
Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(4):661-671. PubMed ID: 37154586
[TBL] [Abstract] [Full Text] [Related]
11. Slow skeletal muscle troponin T acts as a potential prognostic biomarker and therapeutic target for hepatocellular carcinoma.
Huang SC; Huang CC; Ko CY; Huang CY; Liu CH; Lee YK; Chen TY; Hsueh CW; Tzou SJ; Tai MH; Hu TH; Tsai MC; Lee WC; Ho YC; Wu CC; Chang YC; Chang JJ; Liu KH; Li CC; Wen ZH; Chang CL; Chu TH
Gene; 2023 May; 865():147331. PubMed ID: 36871674
[TBL] [Abstract] [Full Text] [Related]
12. The Fibrotic Effects of LINC00663 in Human Hepatic Stellate LX-2 Cells and in Bile Duct-Ligated Cholestasis Mice Are Mediated through the Splicing Factor 2-Fibronectin.
Chu Y; Bao L; Teng Y; Yuan B; Ma L; Liu Y; Kang H
Cells; 2023 Jan; 12(2):. PubMed ID: 36672150
[TBL] [Abstract] [Full Text] [Related]
13. Long non-coding RNAs (lncRNAs) in hepatocellular carcinoma progression: Biological functions and new therapeutic targets.
Hashemi M; Mirzaei S; Zandieh MA; Rezaei S; Amirabbas Kakavand ; Dehghanpour A; Esmaeili N; Ghahremanzade A; Saebfar H; Heidari H; Salimimoghadam S; Taheriazam A; Entezari M; Ahn KS
Prog Biophys Mol Biol; 2023 Jan; 177():207-228. PubMed ID: 36584761
[TBL] [Abstract] [Full Text] [Related]
14. miR-29a-5p regulates the malignant biological process of liver cancer cells through ARID2 regulation of emt.
Li W; Jiang Y; Pan Q; Yang G
Adv Clin Exp Med; 2023 May; 32(5):575-582. PubMed ID: 36530029
[TBL] [Abstract] [Full Text] [Related]
15. Circular RNA hsa_circ_0051040 Promotes Hepatocellular Carcinoma Progression by Sponging miR-569 and Regulating ITGAV Expression.
Ju L; Yao M; Lu R; Cao Y; Wang H; Yuan L; Xiao F; Shao J; Cai W; Chen L; Bian Z
Cells; 2022 Nov; 11(22):. PubMed ID: 36429000
[TBL] [Abstract] [Full Text] [Related]
16. BCAT1, as a prognostic factor for HCC, can promote the development of liver cancer through activation of the AKT signaling pathway and emt.
Ding Y; Wang X; Lu S; Lai A; Xie B; He X; Liu Q
J Mol Histol; 2023 Feb; 54(1):25-39. PubMed ID: 36344754
[TBL] [Abstract] [Full Text] [Related]
17. Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential.
Han Q; Wang M; Dong X; Wei F; Luo Y; Sun X
Front Immunol; 2022; 13():985815. PubMed ID: 36300115
[TBL] [Abstract] [Full Text] [Related]
18. FAM96A and FAM96B function as new tumor suppressor genes in breast cancer through regulation of the Wnt/β-catenin signaling pathway.
Zhang DD; Sun XL; Liang ZY; Wang XY; Zhang LN
Life Sci; 2022 Nov; 308():120983. PubMed ID: 36165859
[TBL] [Abstract] [Full Text] [Related]
19. Long Non-coding RNA DLGAP1-AS1 and DLGAP1-AS2: Two Novel Oncogenes in Multiple cancers.
Zhao F; Tan F; Tang L; Du Z; Chen X; Yang Y; Zhou G; Yuan C
Curr Med Chem; 2023; 30(25):2822-2834. PubMed ID: 36121088
[TBL] [Abstract] [Full Text] [Related]
20. Oncogenic roles of LINC01234 in various forms of human cancer.
Kong M; Yu X; Zheng Q; Zhang S; Guo W
Biomed Pharmacother; 2022 Oct; 154():113570. PubMed ID: 36030582
[TBL] [Abstract] [Full Text] [Related]
[Next]
